BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28903963)

  • 1. Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma.
    Gigliotti CR; Modorati G; Di Nicola M; Fiorino C; Perna LA; Miserocchi E; Franzin A; Picozzi P; Bolognesi A; Mortini P; Del Vecchio A; Calandrino R
    Br J Ophthalmol; 2018 Jun; 102(6):833-839. PubMed ID: 28903963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of radio-induced complications in 194 eyes undergoing gamma knife radiosurgery for uveal melanoma.
    Cicinelli MV; Di Nicola M; Gigliotti CR; Battista M; Miserocchi E; Del Vecchio A; Mortini P; Bandello F; Modorati GM
    Acta Ophthalmol; 2021 Dec; 99(8):e1458-e1466. PubMed ID: 33638277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Results of Stereotactic Radiosurgery in Uveal Melanoma and Risk Factors for Radiation Retinopathy.
    Özcan G; Gündüz AK; Mirzayev İ; Oysul K; Uysal H
    Turk J Ophthalmol; 2020 Jun; 50(3):156-162. PubMed ID: 32631003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma.
    Joye RP; Williams LB; Chan MD; Witkin AJ; Schirmer CM; Mignano JE; Wazer DE; Yao KC; Wu JK; Duker JS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):125-31. PubMed ID: 24635153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinvasive tumor endoresection in combination with ocular stereotactic radiosurgery.
    Sinyavskiy OA; Troyanovsky RL; Ivanov PI; Golovin AS; Tibilov AV; Solonina SN; Astapenko AM; Zubatkina IS
    J Neurosurg; 2016 Dec; 125(Suppl 1):58-63. PubMed ID: 27903184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
    JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
    Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retina dose as a predictor for visual acuity loss in
    Heilemann G; Fetty L; Blaickner M; Nesvacil N; Zehetmayer M; Georg D; Dunavoelgyi R
    Radiother Oncol; 2018 Jun; 127(3):379-384. PubMed ID: 29452902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
    Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
    Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of single fraction Leksell stereotactic radiosurgery in the treatment of uveal melanoma.
    Rennie I; Forster D; Kemeny A; Walton L; Kunkler I
    Acta Ophthalmol Scand; 1996 Dec; 74(6):558-62. PubMed ID: 9017041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereotactic Rediosurgery for Uveal Melanoma; Postradiation Complications].
    Furdová A; Šramka M; Waczulíková I; Chorváth M; Trompak O; Krčová I; Horkovičová K
    Cesk Slov Oftalmol; 2015 Jun; 71(3):134-42. PubMed ID: 26201359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.